At BTG we are focused on bringing to market innovative products in specialist areas of medicine to better serve doctors and patients. Our growing portfolio of Interventional Medicine products is designed to advance the treatment of liver tumours, advanced emphysema, severe blood clots, and varicose veins, while our Specialty Pharmaceuticals portfolio offers antidotes that alleviate toxicity and treat rare conditions. Healthcare is constantly evolving – so BTG never stands still. Inspired by a deep understanding of our customers’ needs, we’re working to meaningfully improve the lives of patients and their healthcare experience. Our competitive advantage is our dedication to finding smart, often unconventional solutions to complex medical problems. Many of our products combine medicines, device technology and new techniques in order to deliver more targeted treatments. We also invest in the clinical evidence that helps demonstrate the value of our products to doctors, patients, and healthcare systems. Doing what’s right for patients is what gets us to work in the morning. It’s part of our DNA. By staying true to this principle and our values, we’ve earned a strong reputation for the quality of our products and our commitment to innovation. Whether developed in our own labs or in partnership with clinicians, academics, and other companies, we believe passionately that medical innovation has the power to improve human health. Imagine where we can go.
Show more

Employee Rating

Parent CompanyBoston Scientific
HQLondon, GB
Cybersecurity ratingBMore
BTG was founded in 1948 and is headquartered in London, GB

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at BTG

Louise Makin

Louise Makin

Duncan Kennedy

Duncan Kennedy

Melanie Lee

Melanie Lee

Chief Scientific Officer
Jamie Heath

Jamie Heath

Chief Development Officer
John Sylvester

John Sylvester

Chief Commercial Officer
Show more

BTG Office Locations

BTG has offices in London, Camberley, Ffostrasol, Surrey and in 10 other locations
London, GB (HQ)
5 Fleet Pl
Camberley, GB
Watchmoor Park, Riverside Way
Ffostrasol, GB
Blaenwaun, Llandysul Ceredigion
Surrey, GB
Park, Weydon Lane
Rosedale, AU
129 Holland Rd
Ottawa, CA
11 Hines Rd #200, Kanata
Show all (16)

BTG Financials and Metrics

Summary Metrics

Founding Date

BTG is a subsidiary of Boston Scientific

BTG Revenue

Embed Graph
View revenue for all periods
BTG's revenue was reported to be £731.28 m in FY, 2019
GBPFY, 2016FY, 2017FY, 2018FY, 2019



Revenue growth, %


Cost of goods sold


Gross profit

GBPFY, 2016FY, 2017FY, 2018FY, 2019



Accounts Receivable




Current Assets

GBPFY, 2016FY, 2017FY, 2018FY, 2019

Net Income


Cash From Operating Activities


Cash From Financing Activities


Net Change in Cash

GBPFY, 2016



Financial Leverage

1.4 x
Show all financial metrics

BTG Acquisitions / Subsidiaries

Company NameDateDeal Size
Novate MedicalSeptember 11, 2018$150 m

BTG Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

BTG Online and Social Media Presence

Embed Graph

BTG News and Updates

Pro-growth agenda and positive outlook for capital markets highlighted at BTG Pactual CEO Conference 2020

SÃO PAULO , Feb. 21, 2020 /PRNewswire/ -- Progress on fiscal and tax reforms, the government´s privatization program and the outlook for capital markets were some of the themes debated at the panels and presentations of the 21st BTG Pactual CEO Conference, held on Tuesday (18) and...

BTG Pactual founder says Brazil's 2% growth "not brilliant"

The founder of Banco BTG Pactual SA said on Wednesday that Brazil's expected 2020 economic growth of around 2% "is not brilliant," and only productivity improvements would allow the country to grow more quickly.

BTG Pactual founder Esteves returns to center stage amid speculation on role

Banco BTG Pactual SA founder Andre Esteves will be the marquee speaker at a wide-ranging event on Tuesday sponsored by the Brazilian investment bank, marking a return to the limelight for one of the country's best-known bankers.

BTG Pactual's profit surges on higher trading gains, fees

Latin America's largest investment bank, Banco BTG Pactual SA, reported a 56.6% rise in third-quarter net income on Tuesday on higher trading gains and investment banking fees.

Brazil's BTG Pactual says recent probes had no impact on asset management unit

Brazilian bank Banco BTG Pactual SA said its asset management unit had maintained the influx of new money in spite of two recent police investigations at the bank, its asset management Chief Executive Eduardo Guardia told journalists on Tuesday.

Brazil prosecutors probe Banco BTG Pactual over rate decision access - statement

Brazilian federal prosecutors are investigating Banco BTG Pactual SA over allegations it had illegal access to interest rate decisions between 2010 and 2012, the prosecutors' office said in a statement.
Show more

BTG Frequently Asked Questions

  • When was BTG founded?

    BTG was founded in 1948.

  • Who are BTG key executives?

    BTG's key executives are Louise Makin, Duncan Kennedy and Melanie Lee.

  • How many employees does BTG have?

    BTG has 600 employees.

  • What is BTG revenue?

    Latest BTG annual revenue is £731.3 m.

  • What is BTG revenue per employee?

    Latest BTG revenue per employee is £1.2 m.

  • Who are BTG competitors?

    Competitors of BTG include Amicus Therapeutics, Circassia and Recro Gainesville.

  • Where is BTG headquarters?

    BTG headquarters is located at 5 Fleet Pl, London.

  • Where are BTG offices?

    BTG has offices in London, Camberley, Ffostrasol, Surrey and in 10 other locations.

  • How many offices does BTG have?

    BTG has 16 offices.